Institute for Clinical and Economic Review (ICER)
Dmitriy Nikitin is a seasoned public health researcher with a robust background in health policy and management. Currently serving as a Senior Research Lead at the Institute for Clinical and Economic Review since November 2020, Dmitriy has previously held roles including Research Lead at Rutgers University and Researcher at the University of North Carolina at Chapel Hill, where significant work included the Internet Tobacco Vendor Study and projects addressing the opioid epidemic. Dmitriy's extensive experience encompasses a range of public health topics, with a focus on tobacco control, environmental health, and legislative solutions. Dmitriy holds a Master of Science in Public Health from the University of North Carolina at Chapel Hill and a Bachelor's Degree in Public Health Policy from UC Irvine.
This person is not in any teams
Institute for Clinical and Economic Review (ICER)
The Institute for Clinical and Economic Review (ICER) is an independent, non-profit research institute that conducts evidence-based reviews of health care interventions, including prescription drugs, other treatments, and diagnostic tests. In collaboration with patients, clinical experts, and other key stakeholders, ICER analyzes the available evidence on the benefits and risks of these interventions to measure their value and suggest fair prices. ICER also regularly reports on the barriers to care for patients and recommends solutions to ensure fair access to prescription drugs. For more information about ICER, please visit www.icer.org.